Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.
“While global glaucoma treatment guidelines and practice are shifting towards more first-line use of SLT, practical challenges have limited it from becoming more widely used as a primary therapy,” Sean Clark, president of global surgical franchise at Alcon, told Healio. “DSLT delivers precise treatment in a patient- and physician-friendly experience, and leveraging Alcon’s footprint as the global leader in eye care will help